Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy
NCT04903340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2022-03-31
Summary
Post-processing of Positron Emission Tomography (PET) acquired images, performed following radioembolization treatment with microspheres at 90Y in hepatocellular carcinoma patients, is subject to changes commercialized by General Electric : respiratory motion correction, specific reconstruction algorithms. We propose to test the possible combinations of these reconstruction parameters to determine which ones to apply for an optimal quality exam with the shortest scan time possible
Conditions
- Carcinoma, Hepatocellular
Interventions
- PROCEDURE
-
PET/CT Exam
PET/CT image processing application of reconstruction parameters: scan time, respiratory gating, Q-clear
Sponsors & Collaborators
-
GE Healthcare
collaborator INDUSTRY -
University Hospital, Bordeaux
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-12
- Primary Completion
- 2021-12-10
- Completion
- 2021-12-10
Countries
- France
Study Locations
More Related Trials
-
Simplification of Low Level Internal Dosimetry
NCT03580161 ·Status: COMPLETED
-
Introduction of Y90-PET-CT Post Radioembolisation Therapy Scans
NCT06123676 ·Status: RECRUITING ·Phase: NA
-
Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA During the Radioembolisation Pretreatment Procedure
NCT06013774 ·Status: COMPLETED ·Phase: NA
-
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
NCT06597539 ·Status: RECRUITING
-
Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques
NCT03151564 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
68Ga-PSMA PET Imaging of Upper Metastatic Gastric Cancers to Determine Eligibility to Endoradiotherapy
NCT05214820 ·Status: RECRUITING ·Phase: PHASE2
-
PET-MRI After Radiofrequency Ablation (RFA) or Microwave Ablation (MWA)
NCT01895673 ·Status: COMPLETED
-
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC
NCT04792801 ·Status: ACTIVE_NOT_RECRUITING
-
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
NCT06334965 ·Status: RECRUITING ·Phase: NA
-
Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the Liver
NCT01219985 ·Status: COMPLETED ·Phase: NA
-
Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization
NCT02848638 ·Status: COMPLETED
-
A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies
NCT05629689 ·Status: RECRUITING ·Phase: PHASE1
-
DCE-MRI for Assessment of Response to TACE of HCC
NCT02878109 ·Status: COMPLETED
-
Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors
NCT02202317 ·Status: COMPLETED ·Phase: NA
-
Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases
NCT03401814 ·Status: COMPLETED
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
PET-CT Based Radiotherapy in Esophageal Cancer Patients
NCT01156831 ·Status: COMPLETED
-
Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
NCT01873469 ·Status: COMPLETED
-
Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT
NCT02119065 ·Status: ACTIVE_NOT_RECRUITING
-
Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization
NCT06232889 ·Status: RECRUITING ·Phase: NA
-
Study of Different Gating Techniques for PET Image of Lung and Liver Lesions
NCT05779865 ·Status: COMPLETED
-
Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging
NCT03303469 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 ·Status: COMPLETED ·Phase: NA
-
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
NCT02088775 ·Status: COMPLETED ·Phase: NA
-
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
NCT04417998 ·Status: COMPLETED ·Phase: PHASE4